Ahmedabad-based Claris Lifesciences Ltd (CLL) has registered net profit of Rs 20 crore for the third quarter ended September 2014 as compared to Rs 15 crore in the previous quarter. Company’s net profit has grown by 32 per cent on quarter-over-quarter basis.
Company’s net consolidated revenues for the quarter under review stood at Rs 162 crore as compared to Rs 151 crore in the previous quarter. The consolidated revenues grew 7 per cent over the previous quarter, the company informed in a statement on Monday.
The company further informed that on October 31, after the receipt of the Board and Shareholder’s approval the Speciality Injectable Business has been transferred to a wholly owned subsidiary; Claris Injectables Limited (CIL).
CLL is now a holding company having three segments, (i) 100 per cent ownership of CIL (ii) 20 per cent stake in COL (JV Company) and (iii) Investments and Cash management of CLL, the statement said